Central Venous Catheter Sales

Central Venous Catheter Sales Market Outlook

The global Central Venous Catheter (CVC) market is projected to reach approximately USD 1.2 billion by 2035, exhibiting a robust compound annual growth rate (CAGR) of around 5.4% during the forecast period from 2025 to 2035. The increasing prevalence of chronic diseases and the growing demand for advanced treatment options, such as chemotherapy and total parenteral nutrition, are driving this market's expansion. Furthermore, an aging population, coupled with the rising number of surgical procedures requiring central venous access, contributes significantly to market growth. The advancement in catheter technology and increasing awareness regarding catheter-related complications are also expected to fuel demand. As healthcare systems worldwide continue to evolve, the importance of effective and safe vascular access is paramount, thereby positively influencing the market for central venous catheters.

Growth Factor of the Market

The growth of the Central Venous Catheter market is influenced by several key factors that shape its trajectory. One of the primary drivers is the alarming rise in the incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, all of which necessitate the use of central venous catheters for effective management and treatment. Additionally, an increase in outpatient procedures has led to a higher demand for these devices across various healthcare settings, including hospitals and specialty clinics. Technological advancements, such as the development of antimicrobial catheters and smart infusion systems, further enhance the appeal of central venous catheters, ensuring their safety and efficacy. The heightened focus on patient-centric care and improved clinical outcomes also encourage the adoption of CVCs in healthcare facilities. Furthermore, the rising number of clinical trials and research activities related to vascular access devices reinforce the market’s growth potential.

Key Highlights of the Market

• Projected market growth at a CAGR of 5.4% from 2025 to 2035.
• Significant rise in demand for CVCs driven by chronic disease prevalence.
• Technological advancements leading to safer, more efficient catheter designs.
• Increased focus on outpatient procedures boosting market expansion.
• Growing awareness around the importance of effective vascular access in patient care.

By Product Type

Tunneled Catheters:

Tunneled catheters are designed for long-term use and are generally indicated for patients requiring extended access to the central venous system, such as those undergoing chemotherapy or long-term parenteral nutrition. These catheters are surgically placed beneath the skin, which minimizes the risk of infection and enhances patient comfort. The increasing demand for long-term therapies, particularly in oncology, is expected to propel the growth of tunneled catheters in the coming years. Moreover, the ability of tunneled catheters to facilitate multiple types of infusions without the need for frequent replacements makes them a preferred choice among healthcare providers. As healthcare providers emphasize the importance of infection control and patient safety, the preference for tunneled catheters is likely to rise.

Non-Tunneled Catheters:

Non-tunneled catheters are primarily used for short-term access to the central venous system and are inserted directly into the vein. They are often employed in critical care settings and during emergency situations where quick vascular access is essential. The rising number of surgical procedures and the urgent need for intravenous therapies, such as blood transfusions and fluid resuscitation, contribute to the growth of non-tunneled catheters in the market. The ease of insertion and immediate access provided by these catheters are significant advantages, making them vital in acute care settings. However, the risk of catheter-related infections and complications associated with non-tunneled catheters necessitates proper insertion techniques and adherence to hygiene protocols, which healthcare providers are continuously improving.

Peripherally Inserted Central Catheters:

Peripherally Inserted Central Catheters (PICCs) are gaining popularity due to their versatility and lower risk of complications compared to traditional central venous catheters. PICCs are inserted through peripheral veins and advance towards the central venous system, providing an effective means for long-term venous access. This capability makes them particularly suitable for patients who require extended treatment duration, such as those undergoing chemotherapy or long-term antibiotics. The growth of the PICC segment is also driven by the increasing adoption of minimally invasive techniques in clinical practices, which promote quicker patient recovery and fewer complications. As hospitals strive to enhance patient outcomes and optimize resource utilization, the demand for PICCs is anticipated to increase significantly in the future.

By Application

Medication Administration:

Medication administration is one of the primary applications of central venous catheters, particularly for patients with chronic illnesses. CVCs facilitate the delivery of medications, including chemotherapy agents, antibiotics, and pain management therapies, directly into the bloodstream. The rising prevalence of conditions requiring intensive medication regimens is driving the demand for CVCs in this application. Additionally, the ability of these catheters to administer multiple medications simultaneously is crucial in managing complex patient cases, especially in oncology and palliative care settings. As the healthcare landscape evolves, the emphasis on effective medication delivery systems will further reinforce the importance of central venous catheters in medication administration.

Parenteral Nutrition:

Parenteral nutrition is another significant application of central venous catheters, particularly for patients who cannot meet their nutritional needs through oral or enteral feeding. CVCs are used to provide total parenteral nutrition (TPN), ensuring patients receive essential nutrients directly into their bloodstream. The growing population of patients with gastrointestinal disorders, cancer, and other conditions that impair nutrient absorption has increased the demand for parenteral nutrition. The trend towards personalized medicine and tailored nutritional support is likely to enhance the acceptance and utilization of CVCs for this application. Furthermore, advancements in TPN formulations and delivery systems are expected to promote the integration of CVCs in nutritional care protocols.

Chemotherapy:

The administration of chemotherapy is a critical application of central venous catheters, especially for patients with cancer requiring frequent and prolonged treatment. CVCs facilitate the delivery of chemotherapeutic agents in a manner that minimizes discomfort and enhances patient compliance. As the incidence of cancer continues to rise globally, the need for effective chemotherapy delivery systems becomes increasingly paramount. Central venous catheters are preferred due to their ability to handle irritant drugs, reducing the risk of complications associated with peripheral venous access. The ongoing advancements in catheter technology aimed at reducing infection rates and improving patient comfort are expected to drive the growth of this segment in the coming years.

Blood Transfusions:

Blood transfusions represent another essential application for central venous catheters, particularly in critical care and surgical settings where rapid access to the vascular system is necessary. CVCs enable the safe and efficient transfusion of blood products, such as red blood cells and platelets, ensuring optimal patient outcomes during emergencies. The increasing incidence of trauma cases, surgeries, and medical conditions requiring blood transfusions are significant factors propelling the demand for central venous catheters in this application. Moreover, the emphasis on patient safety and the reduction of transfusion-related complications enhance the preference for using CVCs over peripheral access methods in transfusion protocols.

Others:

In addition to the aforementioned applications, central venous catheters are utilized in various other medical procedures, including hemodialysis and intravenous fluid administration. The growing prevalence of renal diseases necessitates the use of CVCs for hemodialysis access, further contributing to market growth. The versatility of CVCs in accommodating various medical needs highlights their importance in modern healthcare practices. As more healthcare facilities adopt advanced vascular access techniques, the demand for CVCs in these alternative applications is expected to increase. Furthermore, continuous research into improving catheter designs and functionalities will likely foster the development of new applications for central venous catheters.

By Distribution Channel

Hospitals:

Hospitals represent the largest distribution channel for central venous catheters due to the high volume of surgeries, critical care services, and chronic patient management in these facilities. The need for safe and effective vascular access in diverse medical situations drives the demand for CVCs in hospitals. Furthermore, the presence of specialized departments, such as oncology and nephrology, further enhances the utilization of central venous catheters for various applications, including chemotherapy and hemodialysis. The continuous advancement in hospital infrastructure and technology adoption also plays a significant role in expanding the market for CVCs within hospitals. The growing focus on patient safety and infection control in hospital settings further reinforces the critical role of central venous catheters in medical practice.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are increasingly adopting central venous catheters due to the growing trend of outpatient surgeries and procedures, which require efficient vascular access. The shift towards minimally invasive surgical techniques has resulted in an increased volume of outpatient procedures, thereby creating a demand for CVCs in these settings. ASCs prioritize patient comfort and recovery, and the use of central venous catheters allows for quicker and safer access to the vascular system, facilitating immediate post-operative care. The flexibility offered by CVCs in medication administration and fluid management during outpatient surgeries further enhances their attractiveness in ambulatory care settings. As ASCs continue to evolve and expand their service offerings, the utilization of central venous catheters is expected to grow significantly.

Specialty Clinics:

Specialty clinics, particularly those focused on oncology, nephrology, and pain management, are increasingly incorporating central venous catheters into their treatment protocols. These clinics often manage patients with specific medical needs requiring specialized care, which involves frequent medication administration or parenteral nutrition. The ability of CVCs to provide long-term vascular access makes them indispensable in these settings. Moreover, the rising number of specialty clinics and the growing emphasis on personalized patient care are expected to drive the demand for central venous catheters in this channel. As healthcare systems adapt to the evolving landscape of specialized care, the utilization of CVCs in specialty clinics will continue to rise, ensuring optimal treatment outcomes for patients.

Others:

Other distribution channels, including home healthcare and long-term care facilities, are also emerging as significant contributors to the central venous catheter market. The increase in home healthcare services, especially for patients requiring long-term intravenous therapy or parenteral nutrition, has created a demand for portable and user-friendly catheter systems. Additionally, long-term care facilities cater to an aging population with chronic conditions, necessitating efficient vascular access for various treatments. The growing focus on patient-centered care and the desire to reduce hospital admissions further propel the demand for central venous catheters across these alternative distribution channels. Furthermore, advancements in catheter technology aimed at improving safety and usability in non-hospital settings will likely enhance their adoption in home healthcare.

By Material Type

Polyurethane:

Polyurethane is one of the most commonly used materials for manufacturing central venous catheters due to its favorable properties, including flexibility, biocompatibility, and resistance to kinking. The hydrophilic nature of polyurethane enhances catheter performance and reduces friction during insertion, minimizing patient discomfort. Additionally, polyurethane-based catheters can be produced in various sizes and configurations, allowing for customization based on specific clinical needs. The increasing preference for polyurethane catheters, especially in long-term applications such as chemotherapy and parenteral nutrition, is expected to drive their demand in the market considerably. Continuous advancements in polymer technology further enhance the performance and safety features of polyurethane catheters, reinforcing their market position.

Silicone:

Silicone catheters are renowned for their excellent biocompatibility and low risk of thrombosis, making them ideal for long-term use in patients requiring extended vascular access. The flexibility and softness of silicone catheters contribute to improved patient comfort, reducing the likelihood of complications associated with catheter insertion and maintenance. The growing use of silicone catheters in oncology and palliative care settings, where long-term access is crucial, is expected to propel their market growth. Additionally, the inert nature of silicone minimizes the risk of adverse reactions, making it a preferred material among healthcare providers. As the focus on patient safety and comfort intensifies, the demand for silicone-based catheters is projected to increase significantly in the coming years.

Polyethylene:

Polyethylene is another material used in the production of central venous catheters, particularly for short-term applications. Its cost-effectiveness and ease of manufacturing make it a popular choice for many healthcare facilities. Polyethylene catheters are often utilized in situations requiring temporary vascular access, such as during emergency procedures or for short-term medication administration. However, the susceptibility of polyethylene to kinking and the potential for material degradation over time may limit its use in long-term applications, thereby impacting its market share. Nonetheless, the growing demand for quick and affordable vascular access solutions is expected to sustain the utilization of polyethylene catheters in the market.

Others:

Other materials used in the manufacturing of central venous catheters include specialized polymers and composite materials designed to enhance performance and compatibility. These innovative materials aim to combine the favorable properties of various substances, providing improved resistance to infection and thrombosis while maintaining flexibility and comfort. The increasing awareness of the importance of catheter-related complications has prompted manufacturers to explore novel materials and designs that can mitigate risks. As research and development in catheter technology continue to advance, the adoption of alternative materials in central venous catheter production is expected to grow, further diversifying the market.

By Region

The North American region currently dominates the global Central Venous Catheter market, accounting for nearly 40% of the total market share. This dominance is attributed to the presence of advanced healthcare infrastructure, high healthcare expenditure, and a significant number of surgical procedures performed in hospitals and ambulatory surgical centers. The growing prevalence of chronic diseases, coupled with an aging population, further fuels the demand for central venous catheters in the region. Additionally, the increasing focus on patient safety and infection control, along with the continuous development of innovative catheter technologies, strengthens the market’s growth potential in North America. It is projected that the North American market will experience a CAGR of 5.5% during the forecast period, reflecting robust growth prospects.

In Europe, the Central Venous Catheter market is also witnessing significant growth, driven by the increasing demand for advanced medical devices and rising healthcare expenditure. The region accounts for approximately 30% of the global market share, with major contributions from countries such as Germany, France, and the United Kingdom. The growing prevalence of chronic diseases and the emphasis on improving patient outcomes are key factors contributing to the growth of the CVC market in Europe. Furthermore, regulatory support for medical innovations and rising investments in healthcare infrastructure will likely enhance the adoption of central venous catheters in the region. As the European healthcare landscape evolves, it is anticipated that the market will continue to expand at a steady pace.

Opportunities

The Central Venous Catheter market presents several opportunities for growth and innovation, particularly in the context of evolving healthcare needs and technological advancements. One of the key opportunities lies in the expansion of home healthcare services, which has gained traction in recent years. With an increasing number of patients requiring long-term intravenous therapy or parenteral nutrition, the demand for central venous catheters in home settings is expected to rise. Manufacturers can leverage this opportunity by developing user-friendly and portable catheter systems that facilitate safe and effective home-based care. Additionally, as healthcare systems emphasize reducing hospital admissions and enhancing patient comfort, the integration of central venous catheters into home healthcare protocols is likely to become more prevalent, offering significant market potential.

Another noteworthy opportunity for market growth is the ongoing research and development of advanced catheter materials and designs aimed at improving patient safety and reducing complications associated with catheter use. Innovations such as antimicrobial coatings, smart infusion systems, and enhanced biocompatibility are gaining traction in the market. Companies that prioritize research and development to create cutting-edge products addressing the needs of patients and healthcare providers are likely to capture a significant share of the market. Collaborations between manufacturers and healthcare institutions to conduct clinical trials and studies on the effectiveness of these new technologies can further accelerate their adoption, driving market growth in a competitive landscape.

Threats

Despite the promising growth prospects of the Central Venous Catheter market, several threats could potentially hinder its expansion. One of the primary concerns is the increasing incidence of catheter-related complications, such as infections and thrombosis, which can compromise patient safety and lead to adverse outcomes. The rising awareness regarding these complications may result in healthcare providers being more cautious about catheter usage, potentially limiting the market growth. Additionally, the stringent regulatory requirements for medical devices and the lengthy approval processes can pose challenges for manufacturers in bringing new products to market. As healthcare providers prioritize patient safety and seek to minimize risks, the pressure on manufacturers to deliver high-quality, reliable products will continue to intensify, thereby impacting profitability.

Furthermore, the Central Venous Catheter market may face challenges from the rising competition from alternative vascular access devices, such as midline catheters and peripheral intravenous catheters. As healthcare providers seek more versatile and efficient solutions for vascular access, the preference for these alternatives could impact the demand for traditional central venous catheters. Additionally, the emergence of new technologies and materials in the medical device sector may lead to increased competition and price pressures. Manufacturers must continuously innovate and adapt to changing market dynamics to remain competitive and retain their market share.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Boston Scientific Corporation
• Teleflex Incorporated
• Smiths Medical
• AngioDynamics, Inc.
• Vygon S.A.
• Johnson & Johnson
• ICU Medical, Inc.
• Fresenius Kabi AG
• Cook Medical
• Abbott Laboratories
• Terumo Corporation
• ConvaTec Group PLC
• Halyard Health, Inc.

The competitive landscape of the Central Venous Catheter market is characterized by the presence of several leading players who continuously strive to innovate and enhance their product offerings. Companies like BD (Becton, Dickinson and Company) and Medtronic have established themselves as prominent leaders by focusing on research and development to deliver advanced catheter technologies that prioritize patient safety and comfort. These companies not only invest significantly in product innovation but also engage in strategic partnerships and collaborations to expand their market reach and leverage complementary strengths. The competitive dynamics in this market are further influenced by the need to comply with stringent regulatory standards and the ongoing pressure to reduce healthcare costs, compelling manufacturers to adopt efficient production practices while maintaining high-quality standards.

Teleflex Incorporated and Boston Scientific Corporation are notable competitors in the Central Venous Catheter market, specializing in a variety of medical devices and vascular access solutions. Teleflex, known for its innovative catheter designs and focus on patient safety, has gained a reputation for providing high-quality products that meet the evolving needs of healthcare providers. Boston Scientific, on the other hand, emphasizes its commitment to advancing medical technology through extensive research and development efforts. Both companies have established strong distribution networks and are continuously exploring opportunities for expansion into emerging markets, further enhancing their competitive edge.

Moreover, companies like Smiths Medical and AngioDynamics, Inc. are recognized for their commitment to improving healthcare delivery and patient outcomes through innovative catheter technologies. Smiths Medical offers a diverse portfolio of vascular access products, catering to various medical applications, while AngioDynamics leverages its expertise in vascular access to deliver comprehensive solutions for patient care. As the market continues to evolve, these and other players will likely focus on developing specialized catheters that address specific clinical needs, thereby reinforcing their competitive positions within the Central Venous Catheter market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fresenius Kabi AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ICU Medical, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ConvaTec Group PLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 AngioDynamics, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Halyard Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teleflex Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Central Venous Catheter Sales Market, By Application
    • 6.1.1 Medication Administration
    • 6.1.2 Parenteral Nutrition
    • 6.1.3 Chemotherapy
    • 6.1.4 Blood Transfusions
    • 6.1.5 Others
  • 6.2 Central Venous Catheter Sales Market, By Product Type
    • 6.2.1 Tunneled Catheters
    • 6.2.2 Non-Tunneled Catheters
    • 6.2.3 Peripherally Inserted Central Catheters
  • 6.3 Central Venous Catheter Sales Market, By Material Type
    • 6.3.1 Polyurethane
    • 6.3.2 Silicone
    • 6.3.3 Polyethylene
    • 6.3.4 Others
  • 6.4 Central Venous Catheter Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Central Venous Catheter Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Central Venous Catheter Sales market is categorized based on

By Product Type

• Tunneled Catheters
• Non-Tunneled Catheters
• Peripherally Inserted Central Catheters

By Application

• Medication Administration
• Parenteral Nutrition
• Chemotherapy
• Blood Transfusions
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Material Type

• Polyurethane
• Silicone
• Polyethylene
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Boston Scientific Corporation
• Teleflex Incorporated
• Smiths Medical
• AngioDynamics, Inc.
• Vygon S.A.
• Johnson & Johnson
• ICU Medical, Inc.
• Fresenius Kabi AG
• Cook Medical
• Abbott Laboratories
• Terumo Corporation
• ConvaTec Group PLC
• Halyard Health, Inc.